within Pharmacolibrary.Drugs.ATC.N;

model N07BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.00017333333333333334,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.415,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N07BA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Varenicline is a partial agonist at the alpha4beta2 nicotinic acetylcholine receptor, used as a smoking cessation aid. It is approved and widely used for helping reduce nicotine craving and withdrawal symptoms in patients attempting to quit smoking.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Zierler-Brown, SL, &amp; Kyle, JA (2007). Oral varenicline for smoking cessation. <i>The Annals of pharmacotherapy</i> 41(1) 95–99. DOI:<a href=&quot;https://doi.org/10.1345/aph.1H310&quot;>10.1345/aph.1H310</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17190845/&quot;>https://pubmed.ncbi.nlm.nih.gov/17190845</a></p></li><li><p>Burstein, AH, et al., &amp; Faessel, HM (2006). Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers. <i>Journal of clinical pharmacology</i> 46(11) 1234–1240. DOI:<a href=&quot;https://doi.org/10.1177/0091270006291837&quot;>10.1177/0091270006291837</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17050788/&quot;>https://pubmed.ncbi.nlm.nih.gov/17050788</a></p></li><li><p>Faessel, HM, et al., &amp; Burstein, AH (2010). A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. <i>Clinical pharmacokinetics</i> 49(12) 799–816. DOI:<a href=&quot;https://doi.org/10.2165/11537850-000000000-00000&quot;>10.2165/11537850-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21053991/&quot;>https://pubmed.ncbi.nlm.nih.gov/21053991</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N07BA03;
